Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
"Curcumin" in Combination With Chemotherapy in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Open-label Study of Safety, Tolerability and Pharmacokinetics of Multiple Doses of BI-CON-02 in Patients With HER2-positive Metastatic Breast Cancer, Previously Treated With Trastuzumab
- Status
- TERMINATED
- Phase
- PHASE1
Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC
- Status
- TERMINATED
- Phase
- PHASE2
A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient
- Status
- COMPLETED
- Phase
- NA
Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based Therapy
- Status
- COMPLETED
- Phase
- PHASE2
PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Fulvestrant 500mg in Patients With Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy of the Use of Refrigerant Helmet to Prevent Alopecia in Patients Treated With Eribulin for Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Quell Opioid Reduction and Pain Relief in Patients With Cancer
- Status
- TERMINATED
- Phase
- NA
Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1